Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 11/01/25
End: 09/01/27
Due: 09/01/28
Phase: N/A
Priority: Normal
Start: 03/31/23
End: 04/08/24
Due: 04/08/25
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Study to Investigate the Improvement of Photosensitivity in Terms of Skin Lesions Associated With CEP Following Administration of Oral ATL-001 (Ciclopirox Oral Solution) in Participants Aged >18 Years of Age With CEP | NCT07024316 | Atlas Molecular Pharma | user2@example.com | None | 2025-11-01 | 2027-09-01 | 2028-09-01 | - | - | 2025-07-14 |
| Study to Assess the Safety and Pharmacokinetics of ATL-001 (Ciclopirox Olamine) in Healthy Volunteers | NCT05647343 | Atlas Molecular Pharma | user2@example.com | None | 2023-03-31 | 2024-04-08 | 2025-04-08 | - | - | 2025-07-14 |